References
[1] Graff-Radford SB. Myofascial pain: diagnosis and management. Curr Pain Headache Rep 2004;8:463–7.10.1007/s11916-004-0068-ySearch in Google Scholar
[2] Aoki KR. Future aspects of botulinum neurotoxins. J Neural Transm 2008;115:567–73.10.1007/s00702-007-0758-9Search in Google Scholar
[3] Müller-Schwefe GHH, Ûberall MA. Dysport® for the treatment of myofascial back pain: results from an open-label, phase II, randomized, multicenter, doseranging study. Scand J Pain 2011;2:25–33.10.1016/j.sjpain.2010.11.002Search in Google Scholar
[4] Qerama E, Fuglsang-Frederiksen A, Jensen TS. The role of botulinum toxin in management of pain: an evidence-based review. Curr Opin Anaesthesiol 2010;23:602–10.10.1097/ACO.0b013e32833c3405Search in Google Scholar
[5] Langevin P, Lowcock J, Weber J, Nolan M, Gross AR, Peloso PM, Roberts J, Graham N, Goldsmith CH, Burnie SJ, Haines T. Botulinum toxin intramuscular injections for neck pain: a systematic review and metaanalysis. J Rheumatol 2010; (December) [Epub].10.3899/jrheum.100739Search in Google Scholar
© 2010 Scandinavian Association for the Study of Pain